The word on The Street in general, suggests a Strong Buy analyst consensus rating for Hansoh Pharmaceutical Group Company Limited with a HK$46.15 average price target.

Based on Hansoh Pharmaceutical Group Company Limited’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of HK$7.59 billion and a net profit of HK$2.42 billion. In comparison, last year the company earned a revenue of HK$5.76 billion and had a net profit of HK$1.65 billion